Skip to main content
Top
Published in: Annals of Surgical Oncology 5/2024

29-01-2024 | Gastrectomy | ASO Research Letter

Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer

Authors: Brian Badgwell, MD, MS, Jeannelyn Estrella, MD, Sinchita Roy-Chowdhuri, MD, PhD, Naruhiko Ikoma, MD, MS, Mariela Blum Murphy, MD, Jaffer Ajani, MD, Paul Mansfield, MD

Published in: Annals of Surgical Oncology | Issue 5/2024

Login to get access

Excerpt

The current National Comprehensive Cancer Network (NCCN) guidelines recommend hyperthermic intraperitoneal chemotherapy (HIPEC) for carefully selected patients with stage IV gastric cancer in the setting of a clinical trial.1 The purpose of this research report is to describe updated follow-up results from the first completed clinical trial of HIPEC for gastric cancer in the United States. …
Literature
1.
go back to reference National Comprehensive Cancer Network Guidelines version 1. Gastric cancer. 2023. www.nccn.org. Retrieved 9 May 2023. National Comprehensive Cancer Network Guidelines version 1. Gastric cancer. 2023. www.​nccn.​org. Retrieved 9 May 2023.
Metadata
Title
Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer
Authors
Brian Badgwell, MD, MS
Jeannelyn Estrella, MD
Sinchita Roy-Chowdhuri, MD, PhD
Naruhiko Ikoma, MD, MS
Mariela Blum Murphy, MD
Jaffer Ajani, MD
Paul Mansfield, MD
Publication date
29-01-2024
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 5/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-024-14953-2

Other articles of this Issue 5/2024

Annals of Surgical Oncology 5/2024 Go to the issue